| Utestående aktier | 10,723,857 shares |
| Insideraktier | 9 862 898 shares |
| Insynsägande | 91,97 % |
| Totalt antal insynspersoner | 39 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
6522 out of 11220Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Viveve Medical, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
5am Co-investors Ii Lp
10% Owner -
|
288 447 | 288 447 | |
|
5AM Partners II, LLC
10% Owner -
|
288 447 | 288 447 | |
|
5AM Ventures II LP
10% Owner -
|
288 447 | 288 447 | |
|
Alta Bioequities Management, LLC
10% Owner -
|
5 455 632 | 5 455 632 | |
|
Alta Bioequities, L.P.
10% Owner -
|
5 455 632 | 5 455 632 | |
| Atkinson James G. CBO & President - [O] | 53 945 | 981 | |
| Lori H Bush Director - [D] | 6 530 | 119 | |
| Steven L Basta Director - [D] | 25 | 25 | |
|
Mark Samuel Colella
Director, 10% Owner -
[D]
|
288 447 | 288 447 | |
|
John D Diekman
10% Owner -
|
288 447 | 288 447 | |
| Kevin J Dunn | 22 500 | ||
| Scott Durbin Chief Executive Officer - [O] | 10 | 10 | |
|
Bioventures III A/C GBS
10% Owner -
|
7 952 805 | 3 598 807 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
GBS Venture Partners Pty, Ltd
10% Owner -
|
3 598 807 | 3 598 807 | |
|
Sachs & Co Goldman
10% Owner -
|
23 688 | 5 304 | |
| Goldman Sachs Group Inc - | 53 042 | 5 304 | |
| Benjamin L Holmes | 515 300 | ||
|
Daniel Janney
Director, 10% Owner -
[D]
|
60 579 | 1 101 | |
| Debora Jorn Director - [D] | 40 109 | 729 | |
|
Timothy P Lynch
10% Owner -
|
3 849 711 | 69 995 | |
|
Daniel Mack
10% Owner -
|
6 581 465 | 119 663 | |
| Mann Gregory W. | 1 492 377 | ||
| Arlene Morris Director - [D] | 2 482 | 45 | |
| H B Brent Norton | 409 000 | ||
|
Nantahala Capital Management, LLC
10% Owner -
|
6 581 465 | 119 663 | |
| Edward H Pendergast | 45 000 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Jon M Plexico
Director, 10% Owner -
[D]
|
22 548 | 410 | |
| Sharon Collins Presnell | 18 000 | ||
| Vincent Puglisi | 609 902 | ||
|
Scott M Rocklage
10% Owner -
|
288 447 | 288 447 | |
| Jim B Robbins SVP, Finance & Administration - [O] | 0 | 0 | |
|
Stonepine Capital, L.p.
10% Owner -
|
3 849 711 | 69 995 | |
| Patricia Scheller Chief Executive Officer, Director - [D] [O] | 45 164 | 821 | |
|
Schwab Andrew J.
10% Owner -
|
288 447 | 288 447 | |
| Carl Simpson Director - [D] | 30 768 | 30 768 | |
| Brigitte Smith Director - [D] | 25 312 | 460 | |
|
Stonepine Capital Management, LLC
Director, 10% Owner -
[D]
|
3 849 711 | 69 995 | |
| Mark R Tauscher | 3 537 565 | ||
| Zaderej Karen L. Director - [D] | 62 347 | 1 134 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i VIVE / Viveve Medical, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i VIVE / Viveve Medical, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-06 | 2022-01-04 | 4 | Morris Arlene | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 1,26 | 22 000 | 22 000 | |||||
| 2022-01-06 | 2022-01-04 | 4 | JORN DEBORA | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 1,26 | 22 000 | 22 000 | |||||
| 2022-01-06 | 2022-01-04 | 4 | Durbin Scott | VIVE | Incentive Stock Option (Right to Purchase) | D | 1,26 | 258 000 | 258 000 | |||||
| 2022-01-06 | 2022-01-04 | 4 | Robbins Jim B | VIVE | Incentive Stock Option (Right to Purchase) | D | 1,26 | 42 000 | 42 000 | |||||
| 2022-01-06 | 2022-01-04 | 4 | Basta Steven L | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 1,26 | 48 000 | 48 000 | |||||
| 2022-01-06 | 2022-01-04 | 4 | Presnell Sharon Collins | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 1,26 | 18 000 | 18 000 | |||||
| 2021-12-17 | 2021-12-15 | 4 | Robbins Jim B | VIVE | Common Stock | D | 1,4300 | −36 | −0 | 0 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Durbin Scott | VIVE | Common Stock | D | 1,4000 | −2 | −0 | 10 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Basta Steven L | VIVE | Common Stock | D | 1,4100 | −28 | −0 | 25 | ||||
| 2021-06-25 | 2021-06-23 | 4 | JORN DEBORA | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 2,73 | 51 700 | 51 700 | |||||
| 2021-06-25 | 2021-06-23 | 4 | Durbin Scott | VIVE | Incentive Stock Option (Right to Purchase) | D | 2,73 | 655 300 | 655 300 | |||||
| 2021-06-25 | 2021-06-23 | 4 | Basta Steven L | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 2,73 | 116 200 | 116 200 | |||||
| 2021-06-25 | 2021-06-23 | 4 | Presnell Sharon Collins | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 2,73 | 39 000 | 39 000 | |||||
| 2021-06-25 | 2021-06-23 | 4 | Morris Arlene | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 2,73 | 51 700 | 51 700 | |||||
| 2021-06-25 | 2021-06-23 | 4 | Robbins Jim B | VIVE | Incentive Stock Option (Right to Purchase) | D | 2,73 | 104 700 | 104 700 | |||||
| 2021-01-22 | 2021-01-20 | 4 | JORN DEBORA | VIVE | Restricted Stock Unit | D | 25 000 | 25 000 | ||||||
| 2021-01-22 | 2021-01-20 | 4 | Durbin Scott | VIVE | Restricted Stock Unit | D | 243 000 | 243 000 | ||||||
| 2021-01-22 | 2021-01-20 | 4 | Morris Arlene | VIVE | Restricted Stock Unit | D | 25 000 | 25 000 | ||||||
| 2021-01-22 | 2021-01-20 | 4 | Robbins Jim B | VIVE | Restricted Stock Unit | D | 39 000 | 39 000 | ||||||
| 2021-01-22 | 2021-01-20 | 4 | Presnell Sharon Collins | VIVE | Restricted Stock Unit | D | 25 000 | 25 000 | ||||||
| 2021-01-22 | 2021-01-20 | 4 | Basta Steven L | VIVE | Restricted Stock Unit | D | 50 000 | 50 000 | ||||||
| 2020-10-30 | 2020-10-28 | 4 | Presnell Sharon Collins | VIVE | Non-Qualified Stock Option (Right to Buy) | D | 0,51 | 330 000 | 330 000 | |||||
| 2020-09-22 | 2020-09-21 | 4 | JORN DEBORA | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 0,54 | 165 000 | 165 000 | |||||
| 2020-09-22 | 2020-09-21 | 4 | Morris Arlene | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 0,54 | 165 000 | 165 000 | |||||
| 2020-09-22 | 2020-09-21 | 4 | Basta Steven L | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 0,54 | 165 000 | 165 000 | |||||
| 2020-02-18 | 3/A | GOLDMAN SACHS & CO See footnotes | VIVE | Common Units | I | 53 042 | ||||||||
| 2020-02-18 | 2019-10-01 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,7700 | −25 | −0 | 0 | ||||
| 2020-02-18 | 2019-10-01 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,5600 | −23 663 | −132 | 25 | ||||
| 2020-02-18 | 2019-09-30 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 4,5500 | −68 737 | −313 | 23 688 | ||||
| 2020-02-18 | 2019-09-27 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,1000 | −5 359 | −27 | 92 425 | ||||
| 2020-02-18 | 2019-09-26 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,2500 | −7 001 | −37 | 97 784 | ||||
| 2020-02-18 | 2019-09-25 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,6200 | −10 799 | −61 | 104 785 | ||||
| 2020-02-18 | 2019-09-24 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,5700 | −800 | −4 | 115 584 | ||||
| 2020-02-18 | 2019-09-24 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,6400 | 26 200 | 148 | 116 384 | ||||
| 2020-02-18 | 2019-09-23 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 6,0500 | −800 | −5 | 90 184 | ||||
| 2020-02-18 | 2019-09-23 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,8400 | 39 600 | 231 | 90 984 | ||||
| 2020-02-18 | 2019-09-20 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | −1 658 | 51 384 | ||||||
| 2019-11-27 | 2019-11-26 | 4 | Zaderej Karen L. | VIVE | Non-Qualified Stock Option (Right to Buy) | D | 0,87 | 330 000 | 330 000 | |||||
| 2019-11-27 | 2019-11-26 | 4 | Robbins Jim B | VIVE | Non-Qualified Stock Option (Right to Buy) | D | 0,87 | 330 000 | 330 000 | |||||
| 2019-11-27 | 2019-11-26 | 4 | JORN DEBORA | VIVE | Non-Qualified Stock Option (Right to Buy) | D | 0,87 | 330 000 | 330 000 | |||||
| 2019-11-27 | 2019-11-26 | 4 | Morris Arlene | VIVE | Non-Qualified Stock Option (Right to Buy) | D | 0,87 | 330 000 | 330 000 | |||||
| 2019-11-27 | 2019-11-26 | 4 | Basta Steven L | VIVE | Non-Qualified Stock Option (Right to Buy) | D | 0,87 | 660 000 | 660 000 | |||||
| 2019-11-27 | 2019-11-26 | 4 | Durbin Scott | VIVE | Non-Qualified Stock Option (Right to Buy) | D | 0,87 | 3 298 000 | 3 298 000 | |||||
| 2019-10-23 | 2019-09-27 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,1000 | −5 359 | −27 | 92 425 | ||||
| 2019-10-23 | 2019-09-26 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,2500 | −7 001 | −37 | 97 784 | ||||
| 2019-10-23 | 2019-09-25 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,6200 | −10 799 | −61 | 104 785 | ||||
| 2019-10-23 | 2019-09-24 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,5700 | −800 | −4 | 115 584 | ||||
| 2019-10-23 | 2019-09-24 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,6400 | 26 200 | 148 | 116 384 | ||||
| 2019-10-23 | 2019-09-23 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 6,0500 | −800 | −5 | 90 184 | ||||
| 2019-10-23 | 2019-09-23 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,8400 | 39 600 | 231 | 90 984 | ||||
| 2019-10-23 | 2019-09-20 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 6,9000 | −1 658 | −11 | 51 384 | ||||
| 2019-10-23 | 2019-10-01 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,7700 | −25 | −0 | 0 | ||||
| 2019-10-23 | 2019-10-01 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 5,5600 | −23 663 | −132 | 25 | ||||
| 2019-10-23 | 2019-09-30 | 4/A | GOLDMAN SACHS GROUP INC See Footnotes | VIVE | Common Units | I | 4,5500 | −68 737 | −313 | 23 688 | ||||
| 2019-10-02 | 2019-10-01 | 4 | GOLDMAN SACHS GROUP INC See footnotes | VIVE | Common Units | I | 5,5600 | −23 688 | −132 | 0 | ||||
| 2019-10-02 | 2019-09-30 | 4 | GOLDMAN SACHS GROUP INC See footnotes | VIVE | Common Units | I | 4,5500 | −68 737 | −313 | 23 688 | ||||
| 2019-09-30 | 3 | GOLDMAN SACHS & CO See footnotes | VIVE | Common Units | I | 106 084 | ||||||||
| 2019-09-30 | 3 | GOLDMAN SACHS & CO See footnotes | VIVE | Common Units | I | 106 084 | ||||||||
| 2019-09-30 | 3 | GOLDMAN SACHS & CO See footnotes | VIVE | Common Units | I | 106 084 | ||||||||
| 2019-09-30 | 3 | GOLDMAN SACHS & CO See footnotes | VIVE | Common Units | I | 106 084 | ||||||||
| 2019-09-30 | 2019-09-27 | 4 | GOLDMAN SACHS GROUP INC See footnotes | VIVE | Common Units | I | 5,0200 | −5 359 | −27 | 92 425 | ||||
| 2019-09-30 | 2019-09-26 | 4 | GOLDMAN SACHS GROUP INC See footnotes | VIVE | Common Units | I | 5,2500 | −7 001 | −37 | 97 784 | ||||
| 2019-09-30 | 2019-09-25 | 4 | GOLDMAN SACHS GROUP INC See footnotes | VIVE | Common Units | I | 5,6300 | −10 799 | −61 | 104 785 | ||||
| 2019-09-30 | 2019-09-24 | 4 | GOLDMAN SACHS GROUP INC See footnotes | VIVE | Common Units | I | 5,6500 | 25 400 | 144 | 115 584 | ||||
| 2019-09-30 | 2019-09-23 | 4 | GOLDMAN SACHS GROUP INC See footnotes | VIVE | Common Units | I | 5,8400 | 38 800 | 227 | 90 184 | ||||
| 2019-09-30 | 2019-09-20 | 4 | GOLDMAN SACHS GROUP INC See footnotes | VIVE | Common Units | I | 7,5300 | −1 658 | −12 | 51 384 | ||||
| 2019-07-02 | 2019-07-01 | 4 | Zaderej Karen L. | VIVE | Common Stock | D | 37 829 | 62 347 | ||||||
| 2019-05-31 | 2019-05-29 | 4 | Basta Steven L | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 0,58 | 35 000 | 35 000 | |||||
| 2019-05-31 | 2019-05-29 | 4 | JORN DEBORA | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 0,58 | 35 000 | 35 000 | |||||
| 2019-05-31 | 2019-05-29 | 4 | Morris Arlene | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 0,58 | 35 000 | 35 000 | |||||
| 2019-05-31 | 2019-05-29 | 4 | Zaderej Karen L. | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 0,58 | 35 000 | 35 000 | |||||
| 2019-05-07 | 3/A | Mack Daniel Please see footnotes below. | VIVE | Common Stock | I | 6 581 465 | ||||||||
| 2019-05-03 | 3 | Nantahala Capital Management, LLC Please see footnotes below. | NONE | Common Stock | I | 13 162 930 | ||||||||
| 2019-05-03 | 3 | Nantahala Capital Management, LLC Please see footnotes below. | NONE | Common Stock | I | 13 162 930 | ||||||||
| 2019-05-03 | 3 | Nantahala Capital Management, LLC Please see footnotes below. | NONE | Common Stock | I | 13 162 930 | ||||||||
| 2019-04-03 | 2019-04-01 | 4 | Basta Steven L | VIVE | Common Stock | D | 24 199 | 24 199 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Zaderej Karen L. | VIVE | Common Stock | D | 14 248 | 24 518 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | JORN DEBORA | VIVE | Common Stock | D | 10 280 | 40 109 | ||||||
| 2019-02-08 | 2019-01-29 | 4 | Atkinson James G. | VIVE | Common Stock | D | 42 420 | 53 945 | ||||||
| 2019-02-08 | 2019-01-29 | 4 | Durbin Scott | VIVE | Common Stock | D | 62 250 | 73 818 | ||||||
| 2019-02-08 | 2019-01-29 | 4 | Robbins Jim B | VIVE | Common Stock | D | 27 778 | 145 346 | ||||||
| 2019-01-16 | 2019-01-15 | 4 | Durbin Scott | VIVE | Incentive Stock Option (Right to Purchase) | D | 1,24 | 630 000 | 630 000 | |||||
| 2019-01-16 | 2019-01-15 | 4 | Robbins Jim B | VIVE | Incentive Stock Option (Right to Purchase) | D | 1,24 | 95 000 | 95 000 | |||||
| 2019-01-16 | 2019-01-15 | 4 | Atkinson James G. | VIVE | Incentive Stock Option (Right to Purchase) | D | 1,24 | 300 000 | 300 000 | |||||
| 2019-01-16 | 2019-01-15 | 4 | Basta Steven L | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 1,24 | 35 000 | 35 000 | |||||
| 2019-01-02 | 2018-12-31 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 21 131 | 60 579 | ||||||
| 2019-01-02 | 2018-12-31 | 4 | Zaderej Karen L. | VIVE | Common Stock | D | 9 524 | 10 270 | ||||||
| 2019-01-02 | 2018-12-31 | 4 | JORN DEBORA | VIVE | Common Stock | D | 10 120 | 29 829 | ||||||
| 2018-10-25 | 2018-10-23 | 4 | JANNEY DANIEL | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 3,47 | 17 500 | 17 500 | |||||
| 2018-10-25 | 2018-10-23 | 4 | JORN DEBORA | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 3,47 | 17 500 | 17 500 | |||||
| 2018-10-25 | 2018-10-23 | 4 | Morris Arlene | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 3,47 | 17 500 | 17 500 | |||||
| 2018-10-04 | 2018-10-01 | 4 | Plexico Jon M | VIVE | Common Stock | D | 4 007 | 22 548 | ||||||
| 2018-10-04 | 2018-10-01 | 4 | JORN DEBORA | VIVE | Common Stock | D | 4 285 | 19 709 | ||||||
| 2018-10-04 | 2018-10-01 | 4 | Zaderej Karen L. | VIVE | Common Stock | D | 746 | 746 | ||||||
| 2018-10-04 | 2018-10-01 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 8 947 | 39 448 | ||||||
| 2018-09-14 | 2018-09-13 | 4 | Zaderej Karen L. | VIVE | Non-Qualified Stock Options | D | 3,45 | 70 000 | 70 000 | |||||
| 2018-09-14 | 2018-09-13 | 4 | Basta Steven L | VIVE | Non-Qualified Stock Options | D | 3,45 | 70 000 | 70 000 | |||||
| 2018-09-13 | 3 | Basta Steven L | VIVE | Common Stock | D | 28 985 | ||||||||
| 2018-09-13 | 3 | Basta Steven L | VIVE | Common Stock | I | 54 970 | ||||||||
| 2018-09-13 | 3 | Basta Steven L | VIVE | Common Stock | D | 28 985 | ||||||||
| 2018-09-13 | 3 | Basta Steven L | VIVE | Common Stock | I | 54 970 | ||||||||
| 2018-09-13 | 3 | Basta Steven L | VIVE | Common Stock | D | 28 985 | ||||||||
| 2018-09-13 | 3 | Basta Steven L | VIVE | Common Stock | I | 54 970 | ||||||||
| 2018-07-03 | 2018-07-02 | 4 | Plexico Jon M | VIVE | Common Stock | D | 4 635 | 18 541 | ||||||
| 2018-07-03 | 2018-07-02 | 4 | BUSH LORI H | VIVE | Common Stock | D | 1 166 | 6 530 | ||||||
| 2018-07-03 | 2018-07-02 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 8 437 | 30 501 | ||||||
| 2018-07-03 | 2018-07-02 | 4 | JORN DEBORA | VIVE | Common Stock | D | 4 040 | 15 424 | ||||||
| 2018-05-23 | 2018-05-22 | 4 | JORN DEBORA | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 1,75 | 17 500 | 17 500 | |||||
| 2018-05-23 | 2018-05-22 | 4 | Plexico Jon M | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 1,75 | 17 500 | 17 500 | |||||
| 2018-05-23 | 2018-05-22 | 4 | Morris Arlene | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 1,75 | 17 500 | 17 500 | |||||
| 2018-05-23 | 2018-05-22 | 4 | JANNEY DANIEL | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 1,75 | 17 500 | 17 500 | |||||
| 2018-05-15 | 2018-05-11 | 4 | Durbin Scott | VIVE | Stock Options (Right to Purchase) | D | 1,97 | 300 000 | 300 000 | |||||
| 2018-05-15 | 2018-05-11 | 4 | Robbins Jim B | VIVE | Stock Options (Right to Purchase) | D | 1,97 | 32 500 | 32 500 | |||||
| 2018-05-15 | 2018-05-11 | 4 | JORN DEBORA | VIVE | Stock Options (Right to Purchase) | D | 1,97 | 150 000 | 150 000 | |||||
| 2018-04-04 | 2018-04-02 | 4 | Plexico Jon M | VIVE | Common Stock | D | 3 543 | 13 906 | ||||||
| 2018-04-04 | 2018-04-02 | 4 | JORN DEBORA | VIVE | Common Stock | D | 3 089 | 11 384 | ||||||
| 2018-04-04 | 2018-04-02 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 6 450 | 22 064 | ||||||
| 2018-04-04 | 2018-04-02 | 4 | BUSH LORI H | VIVE | Common Stock | D | 1 590 | 5 364 | ||||||
| 2018-01-25 | 2018-01-23 | 4 | Scheller Patricia | VIVE | Incentive Stock Option (Right to Purchase) | D | 4,48 | 185 000 | 185 000 | |||||
| 2018-01-25 | 2018-01-23 | 4 | Robbins Jim B | VIVE | Incentive Stock Option (Right to Purchase) | D | 4,48 | 58 750 | 58 750 | |||||
| 2018-01-25 | 2018-01-23 | 4 | Atkinson James G. | VIVE | Incentive Stock Option (Right to Purchase) | D | 4,48 | 150 000 | 150 000 | |||||
| 2018-01-25 | 2018-01-23 | 4 | Durbin Scott | VIVE | Incentive Stock Option (Right to Purchase) | D | 4,48 | 120 000 | 120 000 | |||||
| 2018-01-04 | 2018-01-02 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 4 276 | 15 614 | ||||||
| 2018-01-04 | 2018-01-02 | 4 | JORN DEBORA | VIVE | Common Stock | D | 2 048 | 8 295 | ||||||
| 2018-01-04 | 2018-01-02 | 4 | Plexico Jon M | VIVE | Common Stock | D | 2 349 | 10 363 | ||||||
| 2018-01-04 | 2018-01-02 | 4 | BUSH LORI H | VIVE | Common Stock | D | 964 | 3 774 | ||||||
| 2017-10-04 | 2017-10-02 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 2 872 | 11 338 | ||||||
| 2017-10-04 | 2017-10-02 | 4 | Plexico Jon M | VIVE | Common Stock | D | 2 196 | 8 014 | ||||||
| 2017-10-04 | 2017-10-02 | 4 | JORN DEBORA | VIVE | Common Stock | D | 1 915 | 6 247 | ||||||
| 2017-10-04 | 2017-10-02 | 4 | BUSH LORI H | VIVE | Common Stock | D | 901 | 2 810 | ||||||
| 2017-09-08 | 2017-09-06 | 4 | JORN DEBORA | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 5,58 | 17 500 | 17 500 | |||||
| 2017-09-08 | 2017-09-06 | 4 | JORN DEBORA | VIVE | Common Stock | D | 1 737 | 4 332 | ||||||
| 2017-09-08 | 2017-09-06 | 4 | JANNEY DANIEL | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 5,58 | 17 500 | 17 500 | |||||
| 2017-09-08 | 2017-09-06 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 3 025 | 8 466 | ||||||
| 2017-09-08 | 2017-09-06 | 4 | BUSH LORI H | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 5,58 | 17 500 | 17 500 | |||||
| 2017-09-08 | 2017-09-06 | 4 | Morris Arlene | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 5,58 | 17 500 | 17 500 | |||||
| 2017-09-08 | 2017-09-06 | 4 | Plexico Jon M | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 5,58 | 17 500 | 17 500 | |||||
| 2017-09-08 | 2017-09-06 | 4 | Plexico Jon M | VIVE | Common Stock | D | 2 185 | 5 818 | ||||||
| 2017-08-23 | 2017-08-23 | 4 | Durbin Scott | VIVE | Common Stock | D | 5,2500 | 5 000 | 26 | 11 568 | ||||
| 2017-05-22 | 2017-05-17 | 4/A | Plexico Jon M | VIVE | Common Stock | D | 1 724 | 3 633 | ||||||
| 2017-05-19 | 2017-05-17 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 2 387 | 5 441 | ||||||
| 2017-05-19 | 2017-05-17 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 2 387 | 5 441 | ||||||
| 2017-05-19 | 2017-05-17 | 4 | Plexico Jon M | VIVE | Common Stock | D | 1 592 | 3 501 | ||||||
| 2017-05-19 | 2017-05-17 | 4 | Plexico Jon M | VIVE | Common Stock | D | 1 592 | 3 501 | ||||||
| 2017-05-19 | 2017-05-17 | 4 | JORN DEBORA | VIVE | Common Stock | D | 686 | 2 595 | ||||||
| 2017-03-21 | 2017-03-17 | 4 | Stonepine Capital Management, LLC See Notes | VIVE | Common Stock | I | 4,0000 | 1 250 000 | 5 000 | 3 849 711 | ||||
| 2017-03-21 | 2017-03-17 | 4 | Atkinson James G. By Trust | VIVE | Common Stock | I | 4,0000 | 187 500 | 750 | 285 599 | ||||
| 2017-03-21 | 2017-03-17 | 4 | Atkinson James G. By IRA | VIVE | Common Stock | I | 4,0000 | 187 500 | 750 | 285 599 | ||||
| 2017-03-21 | 2017-03-17 | 4 | Scheller Patricia | VIVE | Common Stock | D | 4,0000 | 12 500 | 50 | 45 164 | ||||
| 2017-03-21 | 2017-03-17 | 4 | JANNEY DANIEL See Footnotes | VIVE | Common Stock | I | 4,0000 | 500 000 | 2 000 | 1 381 955 | ||||
| 2017-03-07 | 2017-03-03 | 4 | Durbin Scott | VIVE | Incentive Stock Option (Right to Purchase) | D | 4,46 | 132 860 | 132 860 | |||||
| 2016-12-28 | 2016-12-23 | 4 | BUSH LORI H | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 5,22 | 25 160 | 25 160 | |||||
| 2016-12-28 | 2016-12-23 | 4 | JORN DEBORA | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 5,22 | 25 160 | 25 160 | |||||
| 2016-12-28 | 2016-12-23 | 4 | Plexico Jon M | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 5,22 | 25 160 | 25 160 | |||||
| 2016-12-28 | 2016-12-23 | 4 | JANNEY DANIEL | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 5,22 | 11 035 | 11 035 | |||||
| 2016-12-28 | 2016-12-23 | 4 | Morris Arlene | VIVE | Non-qualified Stock Option (Right to Purchase) | D | 5,22 | 25 160 | 25 160 | |||||
| 2016-12-28 | 2016-12-23 | 4 | Scheller Patricia | VIVE | Incentive Stock Option (Right to Purchase) | D | 5,22 | 150 000 | 150 000 | |||||
| 2016-12-28 | 2016-12-23 | 4 | Durbin Scott | VIVE | Incentive Stock Option (Right to Purchase) | D | 5,22 | 50 000 | 50 000 | |||||
| 2016-12-28 | 2016-12-23 | 4 | Atkinson James G. | VIVE | Incentive Stock Option (Right to Purchase) | D | 5,22 | 2 250 | 2 250 | |||||
| 2016-12-28 | 2016-12-23 | 4 | Atkinson James G. | VIVE | Incentive Stock Option (Right to Purchase) | D | 5,22 | 75 000 | 75 000 | |||||
| 2016-11-14 | 2016-11-09 | 4 | Plexico Jon M | VIVE | Common Stock | D | 1 109 | 1 909 | ||||||
| 2016-11-14 | 2016-11-09 | 4 | Morris Arlene | VIVE | Common Stock | D | 1 442 | 2 482 | ||||||
| 2016-11-14 | 2016-11-09 | 4 | JORN DEBORA | VIVE | Common Stock | D | 1 109 | 1 909 | ||||||
| 2016-11-14 | 2016-11-09 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 1 775 | 3 054 | ||||||
| 2016-11-14 | 2016-11-09 | 4 | BUSH LORI H | VIVE | Common Stock | D | 1 109 | 1 909 | ||||||
| 2016-08-24 | 2016-08-22 | 4 | JORN DEBORA | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 7,89 | 4 590 | 4 590 | |||||
| 2016-08-24 | 2016-08-22 | 4 | JORN DEBORA | VIVE | Common Stock | D | 800 | 800 | ||||||
| 2016-08-24 | 2016-08-22 | 4 | Morris Arlene | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 7,89 | 4 590 | 4 590 | |||||
| 2016-08-24 | 2016-08-22 | 4 | Morris Arlene | VIVE | Common Stock | D | 1 040 | 1 040 | ||||||
| 2016-08-24 | 2016-08-22 | 4 | JANNEY DANIEL | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 7,89 | 4 590 | 4 590 | |||||
| 2016-08-24 | 2016-08-22 | 4 | JANNEY DANIEL | VIVE | Common Stock | D | 1 279 | 1 279 | ||||||
| 2016-08-24 | 2016-08-22 | 4 | BUSH LORI H | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 7,89 | 4 590 | 4 590 | |||||
| 2016-08-24 | 2016-08-22 | 4 | BUSH LORI H | VIVE | Common Stock | D | 800 | 800 | ||||||
| 2016-08-24 | 2016-08-22 | 4 | Plexico Jon M | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 7,89 | 4 590 | 4 590 | |||||
| 2016-08-24 | 2016-08-22 | 4 | Plexico Jon M | VIVE | Common Stock | D | 800 | 800 | ||||||
| 2016-08-24 | 2016-08-22 | 4 | Smith Brigitte | VIVE | Non-Qualified Stock Option (Right to Purchase) | D | 7,89 | 4 590 | 4 590 | |||||
| 2016-08-24 | 2016-08-22 | 4 | Smith Brigitte | VIVE | Common Stock | D | 1 279 | 25 312 | ||||||
| 2016-06-21 | 2016-06-17 | 4 | Atkinson James G. By IRA | VIVE | Common Stock | I | 5,0000 | 100 000 | 500 | 433 737 | ||||
| 2016-06-21 | 2016-06-17 | 4 | Scheller Patricia | VIVE | Common Stock | D | 5,0000 | 6 000 | 30 | 32 664 | ||||
| 2016-06-21 | 2016-06-17 | 4 | Durbin Scott | VIVE | Common Stock | D | 5,0000 | 1 500 | 8 | 6 568 | ||||
| 2016-06-21 | 2016-06-17 | 4 | Stonepine Capital Management, LLC See | VIVE | Common Stock | I | 5,0000 | 300 000 | 1 500 | 2 599 711 | ||||
| 2016-06-20 | 2016-06-17 | 4 | JANNEY DANIEL See Footnotes | VIVMF | Common Stock | I | 5,0000 | 200 000 | 1 000 | 881 954 | ||||
| 2016-05-20 | 2016-05-11 | 4 | JORN DEBORA | VIVMF | Non-Qualified Stock Option (Right to Purchase) | D | 7,74 | 5 250 | 5 250 | |||||
| 2016-05-20 | 2016-05-11 | 4 | BUSH LORI H | VIVMF | Non-Qualified Stock Option (Right to Purchase) | D | 7,74 | 5 250 | 5 250 | |||||
| 2016-05-20 | 2016-05-11 | 4 | Morris Arlene | VIVMF | Non-Qualified Stock Option (Right to Purchase) | D | 7,74 | 5 250 | 5 250 | |||||
| 2016-05-13 | 2016-05-11 | 4 | Plexico Jon M | VIVMF | Non-Qualified Stock Option (Right to Purchase) | D | 7,74 | 5 250 | 5 250 | |||||
| 2016-04-29 | 2015-08-05 | 4/A | Scheller Patricia | VIVMF | Common Stock | D | 1,0451 | 526 | 1 | 135 662 | ||||
| 2016-03-23 | 3 | Plexico Jon M By Limited Partnership | VIVMF | Common Stock | I | 36 795 364 | ||||||||
| 2016-03-23 | 3 | Plexico Jon M By Limited Partnership | VIVMF | Common Stock | I | 36 795 364 | ||||||||
| 2016-03-15 | 2016-01-04 | 4 | Scheller Patricia | VIVMF | Common Stock | D | 58 597 | 213 815 | ||||||
| 2016-03-15 | 2016-01-04 | 4 | Atkinson James G. | VIVMF | Common Stock | D | 0,7800 | −54 798 | −43 | 92 194 | ||||
| 2016-03-15 | 2016-01-04 | 4 | Atkinson James G. | VIVMF | Common Stock | D | 146 992 | 146 992 | ||||||
| 2016-03-15 | 2016-01-04 | 4 | Robbins Jim B | VIVMF | Common Stock | D | 50 000 | 117 568 | ||||||
| 2016-02-29 | 2016-02-25 | 4 | Scheller Patricia | VIVMF | Common Stock | D | 0,8500 | 588 | 0 | 155 218 | ||||
| 2016-01-29 | 2016-01-27 | 4 | JANNEY DANIEL See Footnotes | VIVMF | Warrant to Purchase Common Stock | I | 0,53 | 0,3500 | 202 000 | 71 | 202 000 | |||
| 2016-01-27 | 2016-01-25 | 4 | Scheller Patricia | VIVMF | Common Stock | D | 0,7000 | 1 428 | 1 | 154 630 | ||||
| 2015-12-28 | 2015-12-23 | 4 | Scheller Patricia | VIVMF | Common Stock | D | 0,7354 | 1 359 | 1 | 153 202 | ||||
| 2015-12-22 | 2015-02-17 | 4 | Robbins Jim B | VIVMF | Warrant to Purchase Common Stock | D | 0,50 | 43 024 | 58 024 | |||||
| 2015-12-18 | 2015-12-16 | 4 | Scheller Patricia | VIVMF | Incentive Stock Option (Right to Purchase) | D | 0,75 | 1 936 001 | 3 097 180 | |||||
| 2015-12-18 | 2015-12-16 | 4 | Colella Mark Samuel | VIVMF | Non-Qualified Stock Option (Right to Purchase) | D | 0,75 | 108 000 | 155 000 | |||||
| 2015-12-18 | 2015-12-16 | 4 | Atkinson James G. | VIVMF | Warrant to Purchase Common Stock | D | 0,70 | 50 000 | 267 733 | |||||
| 2015-12-18 | 2015-12-16 | 4 | Atkinson James G. | VIVMF | Incentive Stock Option (Right to Purchase) | D | 0,75 | 704 000 | 1 239 000 | |||||
| 2015-12-18 | 2015-12-16 | 4 | Smith Brigitte | VIVMF | Non-Qualified Stock Option (Right to Purchase) | D | 0,75 | 108 000 | 155 000 | |||||
| 2015-12-18 | 2015-12-16 | 4 | JANNEY DANIEL | VIVMF | Non-Qualified Stock Option (Right to Purchase) | D | 0,75 | 108 000 | 155 000 | |||||
| 2015-12-18 | 2015-12-16 | 4 | Durbin Scott | VIVMF | Incentive Stock Option (Right to Purchase) | D | 0,75 | 774 001 | 1 239 000 | |||||
| 2015-12-18 | 2015-12-16 | 4 | Robbins Jim B | VIVMF | Warrant to Purchase Common Stock | D | 0,70 | 15 000 | 15 000 | |||||
| 2015-12-18 | 2015-12-16 | 4 | Robbins Jim B | VIVMF | Incentive Stock Option (Right to Purchase) | D | 0,75 | 194 000 | 310 000 | |||||
| 2015-12-18 | 2015-12-16 | 4 | Simpson Carl | VIVMF | Non-QualifiedStock Option (Right to Purchase) | D | 0,75 | 108 000 | 156 811 | |||||
| 2015-11-27 | 2015-11-24 | 4 | Scheller Patricia | VIVMF | Common Stock | D | 0,7000 | 14 285 | 10 | 151 843 | ||||
| 2015-11-27 | 2015-11-24 | 4 | Atkinson James G. By Trust | VIVMF | Common Stock | I | 0,7000 | 109 105 | 76 | 3 485 264 | ||||
| 2015-11-27 | 2015-11-24 | 4 | Atkinson James G. IRA | VIVMF | Common Stock | I | 0,7000 | 642 857 | 450 | 3 376 159 | ||||
| 2015-11-25 | 2015-11-24 | 4 | Alta Bioequities Management, LLC See Footnotes | VIVMF | Common Stock | I | 0,7000 | 857 142 | 600 | 5 455 632 | ||||
| 2015-11-25 | 2015-11-24 | 4 | STONEPINE CAPITAL, L.P. | VIVMF | Common Stock | D | 0,7000 | 2 857 142 | 2 000 | 18 397 682 | ||||
| 2015-11-25 | 2015-11-24 | 4 | JANNEY DANIEL See Footnotes | VIVMF | Common Stock | I | 0,7000 | 857 142 | 600 | 5 455 632 | ||||
| 2015-11-23 | 2015-11-17 | 4 | Scheller Patricia | VIVMF | Common Stock | D | 0,7600 | 10 | 0 | 137 558 | ||||
| 2015-11-23 | 2015-11-17 | 4 | Scheller Patricia | VIVMF | Common Stock | D | 0,7300 | 1 360 | 1 | 137 548 | ||||
| 2015-08-11 | 2015-08-05 | 4 | Scheller Patricia | VIVMF | Common Stock | D | 1,0451 | 526 | 1 | 136 188 | ||||
| 2015-08-11 | 2015-08-05 | 4 | Scheller Patricia | VIVMF | Common Stock | D | 0,8549 | 526 | 0 | 135 662 | ||||
| 2015-07-22 | 2015-06-12 | 4 | Atkinson James G. By Custodian for Child | VIVMF | Common Stock | I | 0,8990 | 30 600 | 28 | 2 733 302 | ||||
| 2015-05-29 | 2015-05-14 | 4 | 5AM Partners II, LLC See | VIVMF | Common Stock | I | 0,3700 | 25 649 | 9 | 288 447 | ||||
| 2015-05-29 | 2015-05-14 | 4 | 5AM Partners II, LLC See | VIVMF | Common Stock | I | 0,3700 | 650 026 | 241 | 7 310 231 | ||||
| 2015-05-29 | 2015-05-14 | 4 | Colella Mark Samuel See | VIVMF | Common Stock | I | 0,3700 | 25 649 | 9 | 288 447 | ||||
| 2015-05-29 | 2015-05-14 | 4 | Colella Mark Samuel See | VIVMF | Common Stock | I | 0,3700 | 650 026 | 241 | 7 310 231 | ||||
| 2015-05-28 | 2015-05-12 | 4 | Atkinson James G. | VIVMF | Warrant to Purchase Common Stock | D | 0,53 | 217 733 | 217 733 | |||||
| 2015-05-21 | 2015-05-12 | 4/A | Atkinson James G. By Trust | VIVMF | Common Stock | I | 0,3700 | 675 675 | 250 | 2 702 702 | ||||
| 2015-05-21 | 2015-05-12 | 4/A | Atkinson James G. By IRA | VIVMF | Common Stock | I | 0,3700 | 2 027 027 | 750 | 2 027 027 | ||||
| 2015-05-21 | 3 | STONEPINE CAPITAL, L.P. | VIVMF | Common Stock | D | 31 081 080 | ||||||||
| 2015-05-21 | 3 | STONEPINE CAPITAL, L.P. | VIVMF | Common Stock | D | 31 081 080 | ||||||||
| 2015-05-14 | 2015-05-12 | 4 | Scheller Patricia | VIVMF | Common Stock | D | 0,3700 | 135 136 | 50 | 135 136 | ||||
| 2015-05-14 | 2015-05-12 | 4 | Robbins Jim B | VIVMF | Common Stock | D | 0,3700 | 67 568 | 25 | 67 568 | ||||
| 2015-05-14 | 2015-05-12 | 4 | Durbin Scott | VIVMF | Common Stock | D | 0,3700 | 40 541 | 15 | 40 541 | ||||
| 2015-05-14 | 2015-05-12 | 4 | Atkinson James G. By Trust | VIVMF | Common Stock | I | 0,3700 | 675 675 | 250 | 3 378 377 | ||||
| 2015-05-14 | 2015-05-12 | 4 | Atkinson James G. By IRA | VIVMF | Common Stock | I | 0,3700 | 2 702 702 | 1 000 | 2 702 702 | ||||
| 2015-05-14 | 2015-05-12 | 4 | JANNEY DANIEL See footnotes. | VIVMF | Common Stock | I | 0,3700 | 2 702 702 | 1 000 | 4 598 490 | ||||
| 2015-05-14 | 2015-05-12 | 4 | Alta Bioequities Management, LLC See footnotes. | VIVMF | Common Stock | I | 0,3700 | 2 702 702 | 1 000 | 4 598 490 | ||||
| 2015-02-18 | 2015-02-17 | 4 | Scheller Patricia | VIVMF | Common Stock Warrant | D | 0,50 | 205 814 | 205 814 | |||||
| 2015-02-18 | 2015-02-17 | 4 | Durbin Scott | VIVMF | Common Stock Warrant | D | 0,50 | 208 140 | 208 140 | |||||
| 2014-10-02 | 2014-09-23 | 4 | GBS Venture Partners Pty, Ltd | PLCSD | Common Stock | D | 0,5300 | 947 872 | 502 | 3 598 807 | ||||
| 2014-10-02 | 2014-09-23 | 4 | GBS Venture Partners Pty, Ltd See footnotes | PLCSD | Common Stock | I | 0,5300 | 947 872 | 502 | 3 598 807 | ||||
| 2014-10-02 | 3 | GBS Bioventures III A/C | PLCSD | Common Stock | D | 7 952 805 | ||||||||
| 2014-10-02 | 3 | GBS Bioventures III A/C See footnotes | PLCSD | Common Stock | I | 7 952 805 | ||||||||
| 2014-10-02 | 3 | GBS Bioventures III A/C | PLCSD | Common Stock | D | 7 952 805 | ||||||||
| 2014-10-02 | 3 | GBS Bioventures III A/C See footnotes | PLCSD | Common Stock | I | 7 952 805 | ||||||||
| 2014-10-02 | 3 | GBS Bioventures III A/C See footnotes | PLCSD | Common Stock | I | 7 952 805 | ||||||||
| 2014-10-02 | 3 | GBS Bioventures III A/C | PLCSD | Common Stock | D | 7 952 805 | ||||||||
| 2014-09-30 | 2014-09-26 | 4 | Colella Mark Samuel | PLCSD | Non-Qualified Stock Option | D | 0,60 | 47 000 | 47 000 | |||||
| 2014-09-30 | 2014-09-26 | 4 | Scheller Patricia | PLCSD | Incentive Stock Option | D | 0,60 | 939 318 | 939 318 | |||||
| 2014-09-30 | 2014-09-26 | 4 | Smith Brigitte | PLCSD | Non-Qualified Stock Option | D | 0,60 | 47 000 | 47 000 | |||||
| 2014-09-30 | 2014-09-23 | 4 | Smith Brigitte | PLCSD | Common Stock | D | 0,5300 | 192 262 | 102 | 3 791 069 | ||||
| 2014-09-30 | 2014-09-23 | 4 | Smith Brigitte See Footnotes | PLCSD | Common Stock | I | 0,5300 | 947 872 | 502 | 3 598 807 | ||||
| 2014-09-30 | 2014-09-26 | 4 | Durbin Scott | PLCSD | Incentive Stock Option | D | 0,60 | 382 420 | 382 420 | |||||
| 2014-09-30 | 2014-09-26 | 4 | Robbins Jim B | PLCSD | Incentive Stock Option | D | 0,60 | 116 000 | 116 000 | |||||
| 2014-09-30 | 2014-09-26 | 4 | Simpson Carl | PLCSD | Non-Qualified Stock Option | D | 0,60 | 47 000 | 47 000 | |||||
| 2014-09-30 | 2014-09-26 | 4 | JANNEY DANIEL | PLCSD | Non-Qualified Stock Option | D | 0,60 | 47 000 | 47 000 | |||||
| 2014-09-30 | 3 | Smith Brigitte See footnotes | PLCSD | Common Stock | I | 5 301 870 | ||||||||
| 2014-09-30 | 3 | Smith Brigitte See footnotes | PLCSD | Common Stock | I | 5 301 870 | ||||||||
| 2014-09-26 | 3 | Simpson Carl | PLCSD | Common Stock | D | 30 768 | ||||||||
| 2014-09-26 | 3 | Simpson Carl | PLCSD | Common Stock | D | 30 768 | ||||||||
| 2014-09-26 | 3 | Alta Bioequities, L.P. See footnotes | PLCSD | Common Stock | I | 3 791 576 | ||||||||
| 2014-09-26 | 3 | Alta Bioequities, L.P. See footnotes | PLCSD | Common Stock | I | 3 791 576 | ||||||||
| 2014-09-26 | 3 | Alta Bioequities, L.P. See footnotes | PLCSD | Common Stock | I | 3 791 576 | ||||||||
| 2014-09-26 | 3 | Alta Bioequities, L.P. See footnotes | PLCSD | Common Stock | I | 3 791 576 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 3 349 867 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 1 772 150 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 3 349 867 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 1 772 150 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 3 349 867 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 1 772 150 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 3 349 867 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 1 772 150 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 3 349 867 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 1 772 150 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 1 772 150 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 3 349 867 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 1 772 150 | ||||||||
| 2014-09-25 | 3 | DIEKMAN JOHN D | PLCSD | Common Stock | I | 3 349 867 | ||||||||
| 2014-09-25 | 2014-09-23 | 4 | Colella Mark Samuel | PLCSD | Common Stock | I | 0,5300 | 197 987 | 105 | 262 798 | ||||
| 2014-09-25 | 2014-09-23 | 4 | Colella Mark Samuel | PLCSD | Common Stock | I | 64 811 | 64 811 | ||||||
| 2014-09-25 | 2014-09-23 | 4 | Colella Mark Samuel | PLCSD | Common Stock | I | 0,5300 | 5 017 677 | 2 659 | 6 660 205 | ||||
| 2014-09-25 | 2014-09-23 | 4 | Colella Mark Samuel | PLCSD | Common Stock | I | 1 642 528 | 1 642 528 | ||||||
| 2014-09-25 | 2014-09-23 | 4 | 5AM Partners II, LLC | PLCSD | Common Stock | I | 0,5300 | 197 987 | 105 | 262 798 | ||||
| 2014-09-25 | 2014-09-23 | 4 | 5AM Partners II, LLC | PLCSD | Common Stock | I | 0,5300 | 5 017 677 | 2 659 | 6 660 205 | ||||
| 2014-09-25 | 2014-09-23 | 4 | JANNEY DANIEL See footnotes | PLCSD | Common Stock | I | 0,5300 | 1 895 788 | 1 005 | 1 895 788 | ||||
| 2013-07-22 | 2013-07-16 | 4 | NORTON H B BRENT | PLCSF | Stock Option (Right to Buy) | D | 0,09 | 216 500 | 409 000 | |||||
| 2013-07-22 | 2013-07-16 | 4 | HOLMES BENJAMIN L | PLCSF | Stock Option (Right to Buy) | D | 0,09 | 272 800 | 515 300 | |||||
| 2013-07-22 | 2013-07-16 | 4 | Puglisi Vincent | PLCSF | Stock Option (Right to Buy) | D | 0,09 | 323 000 | 609 902 | |||||
| 2013-07-22 | 2013-07-16 | 4 | TAUSCHER MARK R | PLCSF | Stock Option (Right to Buy) | D | 0,09 | 1 908 565 | 3 537 565 | |||||
| 2013-07-22 | 2013-07-16 | 4 | Mann Gregory W. | PLCSF | Stock Option (Right to Buy) | D | 0,09 | 1 272 377 | 1 492 377 | |||||
| 2012-06-01 | 2012-05-30 | 4 | PENDERGAST EDWARD H | PLCSF | Stock Option (Right to Buy) | D | 0,17 | 45 000 | 45 000 | |||||
| 2012-06-01 | 2012-05-30 | 4 | TAUSCHER MARK R | plcsf | Stock Option (Right to Buy) | D | 0,17 | 70 000 | 70 000 | |||||
| 2012-06-01 | 2012-05-30 | 4 | DUNN KEVIN J | PLCSF | Stock Option (Right to Buy) | D | 0,17 | 22 500 | 22 500 | |||||
| 2012-06-01 | 2012-05-30 | 4 | NORTON H B BRENT | PLCSF | Stock Option (Right to Buy) | D | 0,17 | 22 500 | 22 500 | |||||
| 2012-06-01 | 2012-05-30 | 4 | HOLMES BENJAMIN L | PLCSF | Stock Option (Right to Buy) | D | 0,17 | 22 500 | 22 500 | |||||
| 2012-06-01 | 2012-05-30 | 4 | Puglisi Vincent | PLCSF | Stock Option (Right to Buy) | D | 0,17 | 40 000 | 40 000 | |||||
| 2012-06-01 | 2012-05-30 | 4 | Mann Gregory W. | plcsf | Stock Option (Right to Buy) | D | 0,17 | 70 000 | 70 000 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
